Castillo Renan C, Mackenzie Ellen J, Bosse Michael J
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 21205, USA.
J Trauma. 2011 Dec;71(6):1726-31. doi: 10.1097/TA.0b013e31822c1c33.
The ideal length of follow-up for orthopedic trauma research studies is unknown. This study compares 1- and 2-year complications, clinical recovery, and functional outcomes from a large prospective clinical study.
Patients (n = 336) with limb threatening unilateral lower extremity injuries were followed at the 12, 24, and 84 months. Major outcomes observed were complications requiring hospital re-admission, fracture and wound healing, attainment of full weight bearing status, return to work, and self-reported functional outcome using the Sickness Impact Profile.
The rate of newly observed complications beyond year 1 was small, ranging from 0 to <2%. In addition, 85% to 90% of the clinical recovery outcomes were attained by 1 year, and patients not achieving clinical recovery during the first year had significantly worse functional outcomes. Only 5% of patients returned to work between 1 year and 2 years. Although, a substantial number of patients achieved functional recovery between 1 year and 2 years, of the patients not achieving functional recovery at year 1, 85% of those who would go on to achieve functional recovery during the second year could be predicted using year 1 data.
Although long-term follow-up provides a more complete picture of final outcomes and rate of recovery, follow-up beyond 1 year is difficult and expensive. In our study, it accounted for 20% of the total cost. The analysis of our data suggests that 1-year data were sufficient to address our major study hypotheses.
骨科创伤研究的理想随访时长尚不清楚。本研究比较了一项大型前瞻性临床研究中1年和2年的并发症、临床恢复情况及功能结局。
对336例单侧下肢有肢体威胁性损伤的患者进行了12个月、24个月和84个月的随访。观察的主要结局包括需要再次入院治疗的并发症、骨折和伤口愈合情况、完全负重状态的达成情况、重返工作岗位情况以及使用疾病影响量表自我报告的功能结局。
1年后新观察到的并发症发生率较低,范围为0至<2%。此外,85%至90%的临床恢复结局在1年内达成,第一年未实现临床恢复的患者功能结局明显更差。1年至2年间仅有5%的患者重返工作岗位。虽然相当数量的患者在1年至2年间实现了功能恢复,但对于1年时未实现功能恢复的患者,利用1年的数据可以预测出85%在第二年将实现功能恢复的患者。
虽然长期随访能更全面地呈现最终结局和恢复率,但1年以上的随访困难且昂贵。在我们的研究中,其占总成本的20%。对我们数据的分析表明,1年的数据足以回答我们主要的研究假设。